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Abstract
During growth in presence of choline, both laboratory and clinical Pseudomonas aeruginosa strains synthesize
phosphatidylcholine (PC), and PC makes up ,4% of the total membrane phospholipid content. In all the strains tested,
PC synthesis occurred only when choline is provided exogenously. Mutants defective in synthesis of PC were generated in
the strain backgrounds PAO1 and PA14. Minimum inhibitory concentration studies testing sensitivity of PC-deficient strains
towards various antibiotics and cationic antimicrobial peptides revealed no differences as compared to wild-type strains.
Mutants incapable of synthesizing PC were also found to be unaffected in motility and biofilm formation on abiotic surfaces,
colonization of biotic surfaces and virulence in a mouse infection model. A global phenotypic microarray was further used
to identify conditions wherein membrane PC may play a role of in P. aeruginosa. No culture conditions were identified
wherein wild-type and PC-deficient mutants showed phenotypic differences. Membrane PC may serve a highly specific role
during P. aeruginosa interactions with its eukaryotic hosts based on all the clinical strains tested retaining the ability to
synthesize it during availability of choline.
Citation: Malek AA, Wargo MJ, Hogan DA (2012) Absence of Membrane Phosphatidylcholine Does Not Affect Virulence and Stress Tolerance Phenotypes in the
Opportunistic Pathogen Pseudomonas aeruginosa. PLoS ONE 7(2): e30829. doi:10.1371/journal.pone.0030829
Editor: Olivier Neyrolles, Institut de Pharmacologie et de Biologie Structurale, France
Received September 16, 2011; Accepted December 29, 2011; Published February 17, 2012
Copyright:  2012 Malek et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by National Institutes of Health grants P20-RR018787 from the IDeA Program of the National Center for Research Resources
(to D.A.H.), RO1-AI091702 (to D.A.H.) and NCRR P20-RR021905 (to M.J.W.). The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dhogan@dartmouth.edu
Introduction
Phosphatidylcholine (PC) is an essential phospholipid in
eukaryotes, where it is a critical structural component of cell
membrane, and plays key roles in signaling pathways [1,2,3]. In
contrast, only 10% of prokaryotes synthesize PC, with a higher
frequency in bacterial symbionts and pathogens [4,5]. In
bacteria that produce PC, synthesis occurs mainly using two
pathways: the Pmt- and Pcs-dependent pathways. The Pmt
pathway, which is also conserved in eukaryotes, allows synthesis
of PC de novo [6]. This pathway involves sequential methylation
of phosphatidylethanolamine by phospholipid N-methyltransfer-
ases (PmtA) to yield phosphatidylcholine. The more recently
discovered Pcs pathway is unique to bacteria [7]. In this
pathway, the enzyme phosphatidylcholine synthase (Pcs) cata-
lyzes the condensation of choline directly with CDP-diacylgly-
cerol to form PC.
Several studies have shown that bacterial membrane PC can be
important in host-associated bacteria for symbiosis or pathogen-
esis. PC-deficient mutants of Bradyrhizobium japonicum and Sinorhi-
zobium meliloti exhibit drastically reduced symbiosis with their plant
hosts [8,9]. The plant pathogen Agrobacterium tumifaciens requires
PC for assembly of the T4SS components which are critical for
formation of crown-gall tumors on plants [10,11]. In the human
pathogen Legionella pneumophila, PC-deficient mutants were
attenuated for virulence and had increased susceptibility to
macrophage-mediated killing [12]. These defects were attributed
to decreased effector translocation by the Dot/ICM T4SS, poor
adhesion to macrophages and decreased steady state levels of
flagellin [12]. In Brucella abortus, the pcs mutant had an altered cell
envelope and was unable to establish a replication niche inside
the macrophages, and showed a severe virulence defect in a
mouse model of infection [13,14].
Pseudomonas aeruginosa synthesizes the phospholipids phosphati-
dylethanolamine, cardiolipin, and phosphatidylglycerol and ala-
nyl-phosphatiydylglycerol de novo. A report by Wilderman et al.
[15] has shown that P. aeruginosa can also synthesize PC. It was
further shown that PC production in P. aeruginosa occurs
exclusively in the presence of choline and that synthesis is
dependent on Pcs [15]. However, the significance of PC in P.
aeruginosa membranes for commonly assayed phenotypes had not
been investigated.
In this study, we used a variety of assays for assess the
phenotypes of the pcs mutant relative to the wild-type P. aeruginosa.
We focused on testing whether membrane PC formation impacts
antibiotic resistance, biofilm formation and virulence which are
critical aspects of P. aeruginosa physiology in vivo during infections.
To take an unbiased approach for the characterization of pcs
mutants, we also used a Biolog global phenotypic microarray to
identify culture conditions wherein membrane PC may play a role
of in P. aeruginosa. Either approach revealed no phenotypic
differences between wild-type or PC-deficient mutants suggesting
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30829that membrane PC is dispensable for stress tolerance and
virulence-related attributes in Pseudomonas aeruginosa.
Results and Discussion
Laboratory and clinical strains of P. aeruginosa produce
PC in a choline dependent manner
To study the role of PC in P. aeruginosa membranes, mutants
with in-frame deletions in the phosphatidylcholine synthase (pcs)
gene were constructed in P. aeruginosa PAO1 and PA14, two
laboratory strains. The wild types and their mutant derivatives
were grown in a defined medium with choline and the profiles of
extracted phospholipids were analyzed by thin layer chromatog-
raphy. The PAO1 and PA14 Dpcs mutants completely lacked PC,
and these defects were complemented by expression of the pcs gene
from a separate genomic location (Fig. 1A). PC is produced by
both PAO1 and PA14 strains when grown in LB and MOPS
medium supplemented with choline medium but not in MOPS
medium without choline (Fig. 1B). In LB grown P. aeruginosa,P C
constitutes to 4% of the total phospholipids, while phosphatidyl-
ethanolamine, phosphatidylglycerol and cardiolipin contribute to
73%, 17% and 5% respectively of the total phospholipids [16].
Similar profiles were observed in wild-type strains grown in MOPS
medium with choline (Fig. 1B). Our results were consistent with
those from a previous study in PAO1 [15], and show that PC
synthesis in P. aeruginosa occurs exclusively during availability of
choline, and requires the activity of Pcs.
Several studies have shown that during chronic infections, P.
aeruginosa acquires pathoadaptive mutations that confer benefits
resulting in enhanced persistence and colonization within the host.
Some of the characterized mutations include those in genes
encoding regulators of alginate biosynthesis [17], motility
components [18], regulators of quorum sensing [19] and T3SS
[20]. Therefore, we tested clinical strains of P. aeruginosa isolated
from sputum of patients chronically infected with P. aeruginosa due
to cystic fibrosis to identify whether they have the ability to
synthesize PC and whether the relative amounts were similar.
Clinical strains DH # 220, 228, 214 and 217 weretested, and it was
found that these strains synthesized PC following growth in LB, at
amounts similar to that produced by the PAO1 strain (Fig. S1).
Seven additional clinical isolateswerethen tested for synthesis of PC
in LB as well as MOPS media with or without choline. As shown in
Table S1, all of the strains tested synthesized PC after growth either
in LB or MOPS medium with choline. However, none of the strains
produced PC after growth in minimal medium without choline.
These data show that P. aeruginosa clinical strains have the ability to
Figure 1. Phospholipid profiles of P. aeruginosa strains grown in rich and minimal media. Separation of phospholipids by 1-D thin layer
chromatography and detection by charring with sulphuric acid-methanol solution (1:19, v/v) is shown. (A) Panel showing complementation of the
PAO1 and PA14 Dpcs deletion mutants with pcs gene expressed in trans at a separate genomic location (att::pcs). Phospholipids were extracted from
PAO1 and PA14 strains grown overnight in MOPS-20mM choline. (B) Phospholipid profiles of PAO1 and PA14 strains grown overnight in LB, MOPS-
20mM glucose and MOPS-20mM choline. TLC spots corresponding to PC are shown as black arrowheads. The nature of the spot corresponding to
white arrowheads is observed under all growth conditions just above the PC migration front remains unknown. This spot has been observed under
all growth conditions, regardless of the presence of choline in the medium. Panels A and B are representative images of observations from three
independent experiments. (Slight differences in the migration fronts of PL standards and the extracted phospholipids are likely a result of their acyl
chains varying in lengths and saturation levels).
doi:10.1371/journal.pone.0030829.g001
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likely dependent on the activity of Pcs as in WT strains.
PC-deficient mutants are not affected in their sensitivity
towards antibiotics and antimicrobial peptides
Liposome studies have shown that artificially generated PC-rich
membranes are relatively more resistant to cationic antimicrobial
peptides (CAMPs) [21]. Additionally, in Haemophilus influenzae,
decoration of LPS with phosphorylcholine epitopes, results in
increased resistance to the human cationic peptide LL-37,
presumably due the orientation of the positively charged amine
group of choline towards the outer surface of bacteria, effectively
decreasing the binding affinity of CAMPs [22]. Based on these
studies, we hypothesized that PC production in P. aeruginosa could
specifically alter resistance to cationic antimicrobial peptides. To
test this, the sensitivity of PAO1 Dpcs mutant to the CAMPs:
polymyxin-B and human LL-37 was assayed. Table 1 shows that
no differences in MICs towards these peptides were observed
between the Dpcs mutant and WT. Thus loss of PC in P. aeruginosa
does not alter resistance to CAMPs.
In Brucella abortus, a PC-deficient mutant was proposed to have
altered cell surface properties compared to the WT strain, based
on changes in its resistance profiles to a broad range of antibiotics
[14]. To test if PC that is synthesized when choline is available
affected antibiotic resistance, we tested the sensitivity of PAO1
Dpcs mutant to a variety of antibiotics and compared it to PAO1
WT. In P. aeruginosa, the ability to synthesize PC was not found to
affect the sensitivity towards any of the antibiotics tested (Table 1),
suggesting that the properties of membranes are not altered
drastically in PC-deficient strains.
In comparison to B. abortus, where PC is a major component of
the phospholipid membranes (28% of the total phospholipid) [13],
PC is a minor component in P. aeruginosa membranes (4% of the
total phospholipid) (Fig. 1B). Based on the lack of phenotype of Dpcs
mutant in MIC experiments, it is possible that the relatively small
amount of PC produced by P. aeruginosa, in choline containing
media, does not alter the effective surface charge of the membranes.
To test this, we compared the binding of Cytochrome C to PAO1
WT and PAO1 Dpcs mutant. Cytochrome C is highly positively
charged and the binding of the molecule is dependent on the
negative charge of the bacterial surface [23]. No differences were
observed between the PAO1 WT and PAO1 Dpcs mutant in the
Cytochrome C binding assay (data not shown), suggesting that
synthesisofPCbytheactivityofPcsdoesnotgrosslyaltertheoverall
cell surface charge of P. aeruginosa.
PC-deficient mutants are not altered in their motility and
biofilm formation on abiotic surfaces
P. aeruginosa displays three types of motility: type IV pilus-
mediated twitching motility and flagellum-mediated swimming
and swarming motilities. All these forms of motility involve
complex membrane-spanning systems, in the form of flagellar or
pili components [24]. Based on this, we hypothesized that changes
in P. aeruginosa membranes due to PC production may impact
motility. Fig. 2A shows the results of a twitching motility assay
Table 1. A PC-deficient P. aeruginosa mutant resembles WT in
its sensitivity to antibiotics and antimicrobial peptides.
MIC mg/ml
Growth medium and strains
MOPS-20mM
Glucose MOPS-20mM Choline
Antibiotics and
antimicrobial peptides PAO1 WT PAO1 WT PAO1 Dpcs
Ciprofloxacin 22 2
Tobramycin 44 4
Gentamicin 1.125 1.125 1.125
Kanamycin 125 125 125
Tetracycline 75 75 75
Polymyxin 2.25 2.25 2.25
LL-37 33 3
MICs (mg/ml) were determined by serial two-fold dilution method.
doi:10.1371/journal.pone.0030829.t001
Figure 2. PC-deficient mutants are not affected for motility and
biofilm formation on abiotic surfaces. (A) Twitching motility assays
of PA14 strains on LB and tryptone agar plates were performed as
previously described [28]. Motility was determined by measuring
diameter (mm) of the zone of expansion from the point of inoculation.
(B) Biofilm assays of PA14 strains grown in LB and MOPS-20mM choline
media were performed using 96-well PVC microtiter plates as previously
described [28]. At 12 hours, the biofilms formed were stained with
crystal violet, solubilized with 95% ethanol, and quantified by
measuring absorbance at 595 nm. In panels A and B, values represent
averages and error bars are SD (n=3). Tests of significance were
conducted using a one- way analysis of variance (ANOVA) with a
Bonferroni multiple comparison test, ***P,0.001,
nsP.0.05.
doi:10.1371/journal.pone.0030829.g002
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produced under these medium conditions, data not shown). While
the pili-defective mutants had 4- and 3.5-fold smaller diameters of
twitching zones compared to PA14 WT on LB and tryptone plates
respectively (P values,0.001), the zones of twitching in PC
deficient mutants resembled that of WT. Similarly, standard
motility plate-based assays showed that PC deficient strains were
not affected in swimming and swarming motilities (data not
shown).
P. aeruginosa also forms biofilms on abiotic surfaces that are
highly complex and differentiated, and defects in motility alter
biofilm formation [25]. The capacity of P. aeruginosa to form
biofilms is thought to be an important for its ability to cause
chronic infections and for persisting on implanted medical devices
[26]. The PC-deficient strains were assayed for biofilm formation
on plastic using 96-well microtiter plates. While the pel mutant,
which is defective in synthesis of extracellular matrix [27], and the
flagellum-deficient flgK mutant [28] formed biofilms that were
significantly smaller than WT (P values,0.001) as previously
published, PC-deficient mutants were not altered in their ability to
form biofilms (Fig. 2B). These data show that PC formation does
not impact P. aeruginosa motility or biofilm formation on abiotic
surfaces.
PC is not required for colonization of biotic surfaces or
virulence
To assess the role of PC in host cell-pathogen interactions, PC-
deficient P. aeruginosa strains were tested for colonization of
eukaryotic host surfaces using two model systems: the human
airway epithelial cell co-culture model [29,30] and the fungal co–
culture model [31].
In the airway epithelial cell model, P. aeruginosa PAO1
colonization was assessed after co-culture for 1 hour for enumer-
ating initial attachment and after 6 hours for enumerating biofilm
formation. At each of these time points, microscopic examination
revealed that the integrity of epithelial cell monolayers had not
been compromised following addition of P. aeruginosa (data not
shown). Fig. 3A shows that after 1 h post inoculation, about 25%
of the cells present in the initial inocula of P. aeruginosa PAO1 WT
and PAO1 Dpcs had attached to the epithelial cells. In contrast, the
PAO1 flgk::Tn7 mutant showed a 15-fold lower initial attachment
(P value ,0.001), as has been described previously [30]. At
5 hours post initial attachment, a 10-fold increase in both P.
aeruginosa PAO1 WT and PAO1Dpcs CFUs was observed due to
growth of the strains, whereas the PAO1 flgk::Tn7 showed 5.5 fold
lower CFUs (P value ,0.001) compared to the PAO1 WT and
PAO1Dpcs strains (Fig. 3B).
In the fungal co-culture model, PA14 strains and the
constitutively-filamentous Candida albicans nrg1/nrg1 strains were
cultured for 48 hours. Under these conditions P. aeruginosa PA14
WT attach, form biofilms on the fungal surface, and eventually kill
the fungus [31]. As shown in Fig. 3C, the addition of choline to the
culture medium enhanced PA14 WT biofilm formation. However,
comparison of PA14 WT and PA14Dpcs biofilms on the fungal
surface in medium with choline revealed no distinguishable
differences (Fig. 3C).
Several studies have shown hemolytic phospholipase C (PlcH)
and T3SS to play key roles in P. aeruginosa virulence towards its
eukaryotic hosts [31,32,33,34,35,36,37,38,39]. Using in vitro
assays, we tested whether changes in P. aeruginosa membranes
due to PC synthesis affects the production of these virulence
factors. PlcH activity was analyzed using the artificial substrate p-
nitrophenyl-phosphorylcholine (NPPC) [40]. Cultures of PA14
WT, Dpcs and DplcHR were grown in defined medium with or
without choline and the supernatants were analyzed for NPPC
activity. In WT supernatants, presence of choline in the medium
resulted in 6-fold higher phospholipase C activity while no
increase in activity was observed in the DplcHR strain, a mutant
defective in synthesis of phospholipase C (P value ,0.001). In
comparison, no difference in induction of NPPC activity was
observed in Dpcs mutant as compared to WT (P value .0.05)
(Fig. 4A). While P. aeruginosa PAO1 strains can form biofilms on
airway epithelial cells in a co-culture model as described above,
Figure 3. PC-deficient mutants are not affected for coloniza-
tion of biotic surfaces. Initial attachment and biofilm formation of
PAO1 strains on epithelial cells was performed as previously described
[29,30]. Seven-day-old confluent monolayers of CFBE epithelial cells
were inoculated with bacterial strains and CFUs were estimated at (A)
1 hour post infection for enumerating initial attachment and (B)
6 hours post infection for enumerating biofilm formation. Values in A
and B represent averages and SD from three independent replicates,
and statistical significance of data was evaluated using a two-tailed
unpaired t test, ***P,0.001,
nsP.0.05. (C) Phase contrast micrographs
show 48-hour biofilms formed by P. aeruginosa PA14 strains on the
fungus Candida albicans. PA14 strains were co-cultured with constitu-
tively-filamentous Candida albicans nrg1/nrg1 strain as previously
described [31]. The media used were MG (MOPS 30 mM glucose) and
MGC (MOPS 20 mM glucose, 10 mM choline). Note: Presence of choline
enhances colonization. The micrographs are representative images of
from three independent experiments.
doi:10.1371/journal.pone.0030829.g003
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T3SS-dependent manner [29,30]. T3SS-mediated virulence was
assayed in PA14 strains by analyzing cytotoxicity towards airway
epithelial cells. A PA14 DpscC, strain, with a mutation in a
structural component of the T3SS translocase, showed 4-fold
lower percent cytotoxicity as compared to PA14 WT (P value
,0.001). In comparison, PA14 Dpcs was not defective in T3SS
mediated-cytotoxicity towards epithelial cells (Fig. 4B).
To assess the role of membrane PC in fitness in vivo during
infections, we tested PAO1 WT and the isogenic pcs mutant in a
mouse model of acute pneumoniae [41]. Following oropharyngeal
inoculation of equivalent ratios of PAO1 WT and PAO1 Dpcs
mutant into C57Bl/6J mice (3610
7 CFU/animal), numbers of
CFUs recovered from the lungs were determined at 24 hours post
infection. No differences in bacterial burden were observed
24 hours post infection suggesting that the absence of PC did
not affect virulence in vivo (Fig. 4C). In addition, levels of
infiltrating white blood cells were similar in PAO1 WT and
PAO1Dpcs mutant-infected mice (Fig. S2), suggesting that there
were no significant differences in airway inflammation.
These data collectively suggest that absence of PC in P.
aeruginosa membranes does not affect colonization of biotic
surfaces, virulence and the ability to cause an efficient infection
process in mice.
Comparison of PA14 WT and PA14 Dpcs using Biolog
phenotypic microarrays
Our attempts to identify a role of PC, using a candidate
approach focused at aspects of P. aeruginosa persistence, virulence
and antibiotic stress survival could not detect any obvious
associated phenotypes in the PC-deficient strains. Based on this,
we took an unbiased approach and compared a PC-deficient
mutant and WT using a Biolog phenotypic microarray (Biolog,
Hayward, CA), to identify the role of membrane PC in P.
aeruginosa physiology. The assays were performed with IF-10
medium (Biolog, Hayward, CA) supplemented with 1 mM
choline chloride. Under these conditions, P. aeruginosa formed
PC in its membranes as determined by analysis of phospholipid
profiles by TLC (data not shown). In this study, PM plates 9–20
were used which allowed analysis of growth under 1152 different
culture conditions (http://www.biolog.com/pdf/PM11-PM20.
pdf). This was used for a comparative analysis of sensitivity
towards variations in osmolarity and pH, and a suite of
antibiotics, antimicrobial peptides and chemical inhibitors. A
similar strategy has previously been used to assign a functional
role to the phospholipid alanyl-phosphatidylglycerol which is
formed by P. aeruginosa under acidic conditions (pH 5.3), and
contributes to 6% to the overall lipid content [42]. The study
found alanyl-PG to confer resistance to killing by cationic
peptide protamine, the osmolyte sodium lactate and antibiotic
cefsulodin.
In 98% of the culture conditions tested in our study, PA14 WT
and PA14 Dpcs mutant were indistinguishable in duplicate runs
(yellow growth kinetic curves, Fig. S3). No differences were
observed in the growth kinetics of PA14 WT and Dpcs mutants in
the presence of antibiotics: tetracycline (PM12, wells A5–A8),
carbenicillin (PM12, wells A9–A12), polymyxin B (PM12, wells
B9–B12), tobramycin (PM12, wells F1–F4), ciprofloxacin (PM 20,
wells D5–G8), gentamicin (PM11,wells G5–G8) and kanamycin
(PM11, wells H5–H8) and the cationic antimicrobial peptide:
protamine sulphate (PM16, wells C5–C8) (Fig. S3) which is
consistent with our previous observations in MIC experiments and
our hypothesis that the absence of PC does not drastically alter the
physicochemical properties or the overall surface charge of P.
aeruginosa membranes (Table 1). Although a few differences were
observed (listed in Fig. S3), none of these differences were present
in both replicate runs. Two of the compounds tested that showed
differences in their effects on the pcs mutant as compared to the
Figure 4. PC-deficient mutants are not defective in virulence.
(A) PA14 PlcH activity was assayed for by measuring NPPC hydrolysis
activity in defined medium with (black bars) or without (white bars)
choline. (B) PA14 T3SS-mediated cytotoxicity towards epithelial cells
was assessed by monitoring LDH release 6 hours post infection. LDH
released from control cells lysed with Triton-X 100 was set as 100%
cytotoxicity. In A and B, error bars represent SD of the means of
triplicate experiments (C) Bacterial burden 24 hours post infection from
whole homogenized lungs of mice inoculated at a high infective dose.
CFU counts from individual mice are plotted with means of each group
denoted by horizontal lines. Means were not significantly different.
Statistical significance of data in panels A, B and C were evaluated using
a two-tailed unpaired t test, ***P,0.001,
nsP.0.05.
doi:10.1371/journal.pone.0030829.g004
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acid, were examined more closely. Growth curves studies were
performed in the presence of these compounds. No differences
were observed in the growth rates of PA14 Dpcs when compared
with PA14 WT strain (data not shown). Based on these results, no
conditions could be identified wherein PA14 WT and PA14 Dpcs
mutants showed phenotypic differences.
Concluding Remarks
Comparative analysis of the various sequenced non-patho-
genic and pathogenic Pseudomonads revealed the pcs gene to be
present exclusively in the latter. The analysis showed that while
P. aeruginosa, the plant pathogens P. syringae and P. fluorescens,a n d
the entomopathogenic P. entomophila harbor the pcs gene, the free
living environmental strains P. stutzeri and P. putida do not have
the pcs gene. Based on these observations, we had hypothesized
that the synthesis of PC could be important for P. aeruginosa host-
pathogen interactions or could confer benefits by promoting
survival under stressful conditions. Our study shows that P.
aeruginosa PC-deficient mutants are indistinguishable from WT in
motility and biofilm formation on abiotic surfaces, colonization
of biotic surfaces, and virulence. Furthermore, MIC assays and
Biolog phenotypic microarray experiments suggest that in the
absence of PC, the properties of the membranes and overall
surface charge of the bacteria are not drastically affected. Since
PC is produced in relatively small amounts, it is possible that its
absence is either tolerated or compensated by a slight increase in
synthesis of the zwitterionic phospholipid phosphatidylethanol-
amine, which is a major phospholipid in P. aeruginosa membranes
(Fig. 1, 2). However, the fact that all of the clinical strains of P.
aeruginosa tested had retained the ability to synthesize PC suggests
that it might serve a highly specialized function during
interaction with eukaryotic hosts. It has been reported that
phospholipid environment can affect topological organization
and assembly of membrane proteins [43,44]. Based on this, one
can imagine that PC could aid in assembly or localization of
specific proteins in P. aeruginosa. This can be investigated in the
future by using a comparative proteomics approach analyzing
t h em e m b r a n ep r o t e o m ep r o f i l e so fW Ta n dP C - d e f i c i e n ts t r a i n s
of P. aeruginosa.
Materials and Methods
Ethics statement
The protocol for animal infection was approved by the
University of Vermont Institutional Animal Care and Use
Committee, in accordance with Association for Assessment and
Accreditation of Laboratory Animal Care guidelines. All proce-
dures were under pentobarbital anesthesia and all efforts were
made to minimize animal suffering.
Bacterial strains, plasmids and growth conditions
The bacterial strains and plasmids used in this study are listed in
Table 2. P. aeruginosa and E. coli strains were maintained on LB
medium at 37uC. LB, a rich medium, and morpholinepropane-
sulphonic acid (MOPS) medium [45], a defined medium were
used for growing the bacteria for the various assays. Glucose or
choline was added at concentrations described in the text as
carbon sources in MOPS medium. When necessary, antibiotics
were used at the following concentrations (mgm l
21): gentamicin
(75) and kanamycin (500) for P. aeruginosa, and gentamicin (15) and
carbenicillin (75) for E. coli. All liquid cultures were grown at 37uC
with vigorous aeration.
Construction of P. aeruginosa PAO1 and PA14 Dpcs
mutant strains
In-frame deletion constructs for pcs were generated using splice-
overlap-extension PCR to amplify and splice the 1-kb regions
immediately upstream and downstream of the pcs gene. The
primers (Table 2) were designed to delete the regions between the
first and last ten amino acids of the pcs ORF. The splice overlap
extension PCR products were subcloned into the pCR 2.1 TOPO
(Invitrogen, USA) and sequenced. The insert was then cut and
ligated into the pEX18-Gm vector and the deletion mutations in P.
aeruginosa were obtained by recombination, as described previously
[46]. Briefly, the pEX18-Gm suicide vector containing the
deletion construct was transformed into E. coli strain S17/lpir.
This E. coli strain was then mated with the recipient P. aeruginosa
strain and single crossover mutants were selected for growth on
gentamicin. Recombinants were screened for loss of the pcs gene
by PCR, after selecting for double crossover events and
concomitant loss of sacB genes by growth on 5% sucrose LB
plates with no NaCl.
Complementation of the P. aeruginosa Dpcs strains
To generate the att::pcs complementation construct, the pcs gene
with 500 bp upstream region was amplified from PAO1 and PA14
genomic DNA using the primers described in Table 2. Each PCR
product was subcloned into the pCR 2.1 TOPO (Invitrogen, USA)
and sequenced. The inserts were excised and cloned into the
pUC18miniTn7TGm plasmid [47]. P. aeruginosa strains were co-
electroporated with pUC18miniTn7TGm constructs and helper
plasmid pTNS2, and integrants were recovered by selection on
antibiotic plates. Correct insertion at the att::Tn7 site was verified
by PCR using primers described by Schweizer et al. [47].
Extraction and analysis of phospholipids by thin-layer
chromatography
Overnight cultures (25 ml) of bacteria grown in rich or
minimal medium were centrifuged, and the pellets were washed
with water, then weighed. Phospholipids were extracted from the
bacterial pellets using a modification of the Folch and Stanley
method [48]. Chloroform:methanol (2:1 vol/vol) was added at a
ratio of 20 ml/g of bacterial pellet. After addition of solvent, the
samples were vortexed briefly, agitated at room temperature,
and filtered using Whatman filter paper drenched with
methanol. 0.2 volumes of 0.9% NaCl was added to filtrates,
followed by vortexing, and centrifugation to separate the organic
and aqueous phase. After aspiration of the upper phase, the
lower phase was dried under nitrogen and dissolved in 100 ml
chloroform and stored at 280uC. Total phospholipids in each
sample were quantitated using a colorimetric assay, based on
phosphorous binding to ammonium ferrothiocyanate [49]. The
amount of total phospholipid in the extracted samples was
estimated from a standard curve generated using phospholipid
standards (range, 0–500 mg). For preparing the phospholipid
standards, egg phosphatidylethanolamine and soybean phospha-
tidylcholine were obtained from Sigma-Aldrich, USA and heart
cardiolipin and egg phosphatidylglycerol were obtained from
Avanti Polar Lipids, USA. After quantitation, the phospholipids
were loaded onto thin Silica Gel 60A plates (Merck, Germany)
and separated using a chloroform-methanol-acetic acid (13:3:1
vol/vol/vol) solvent system. After the desired solvent front was
achieved, the plates were dried and sprayed with sulfuric
acid:methanol (1:19 vol/vol) solution. The plates were dried
again and baked in a high temperature oven till the individual
spots could be visualized.
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concentration assays
Minimum inhibitory concentration assays (MICs) for testing
sensitivity to antibiotics and antimicrobial peptides were
performed using serial two-fold dilution method. The MICs
were determined in sterile 96-well flat-bottomed polystyrene
microtiter plates (Corning, USA). A (50 ul) two-fold dilution
series for each compound was prepared in the microtiter
dishes. Bacterial strains to be tested were grown overnight in
MOPS medium as described, subcultured and grown to an
OD600 of 0.4. The ODs of the cultures were adjusted to 0.1,
and 50 ml of the cultures were used to inoculate the wells. Wells
without any antibiotics served as negative controls and wells
without added bacteria and antibiotics served as controls for
contamination. The plates were incubated at 37uCf o r
24 hours. The MICs were defined as lowest concentrations
of antibiotics and peptides inhibiting visible growth. All the
antibiotic stocks were freshly prepared prior to the assay.
Gentamicin, tobramycin, carbenicillin were obtained from
Sigma Aldrich, USA; polymyxin B, tetracycline, kanamycin
and ciprofloxacin were obtained from RPI, USA; and the
human antimicrobial peptide LL-37 was obtained from QCB,
USA.
Motility assays and biofilm formation on abiotic surfaces
Motility assays and microtiter dish biofilm assays were
performed as described previously by O’Toole et al. [28,50].
Initial attachment and biofilm formation on human
airway epithelial cells
Attachment and biofilm formation on epithelial cells by P.
aeruginosa PAO1 WT and Dpcs mutant was examined using a
protocol previously described by Anderson and O’Toole with
slight modifications [29,30]. P. aeruginosa was grown on CFBE
epithelial cells (CFBE41o
2 human bronchial epithelial cells
homozygous for the DF508 mutation of CFTR). Epithelial cells
were seeded at a concentration of 2610
5 cells/well in 24-well
tissue culture plates and maintained in minimal essential medium
(MEM) (Mediatech, Herndon, VA) with 10% fetal bovine serum,
2 mM L-glutamine, 50 U/ml penicillin, and 50 mg/ml strepto-
mycin. The cells were grown at 37uC and 5% CO2 for 7 to 10
days to allow the formation of confluent cell monolayers and tight
junctions. P. aeruginosa was inoculated at a concentration of
1.2610
7 CFU/ml in 0.5 ml MEM/well (without fetal bovine
serum, penicillin, or streptomycin). The plates were incubated at
37uC and 5% CO2. For enumerating the number of cells after the
initial attachment phase (after 1 hour of co-culture) the epithelial
Table 2. Strains and primers used in this study.
Strain/plasmid Description Lab reference # Source or reference
P. aeruginosa strains
PA14 WT P. aeruginosa PA14 wild type DH122 [53]
PA14 Dpcs In-frame deletion mutant of pcs DH606 This study
PA14 Dpcs att::pcs Dpcs complemented at att site DH1372 This study
PA14 flgK::Tn7 Tn7 insertion in flgK DH2 [28]
PA14 pilB::Tn7 Tn7 insertion in pilB DH11 [28]
PA14 pilC::Tn7 Tn7 insertion in pilC DH12 [28]
PA14 pelA::Tn7 Tn7 insertion in pelA DH97 [27]
PAO1 DpscC In-frame deletion mutant of pscC DH95 This study
PAO1 WT P. aeruginosa PAO1 wild-type DH395 [54]
PAO1 Dpcs In-frame deletion mutant of pcs DH909 This study
PAO1Dpcs att::pcs Dpcs complemented at att site DH920 This study
PAO1 flgK::Tn7 Tn7 insertion in flgK DH1072 [28]
PAO1 DplcH In-frame deletion mutant of plcH DH860 [55]
Plasmids
pEX18Gm Integrating vector in P. aeruginosa for generating in-frame deletions, Gm
r [56]
pUC18miniTn7TGm Integrating vector in P. aeruginosa for generating gene insertions at att::Tn7 sites [47]
Primers
pcs in-frame deletion
GOI-F1 GGTTCTCCTACGCCGACGCCAA
SOE-GOI-R1 TCGCGCCGGGTCGTTCGATAGGTTCACGGG
SOE-GOI-F1 CCCGTGAACCTACGAACGACCCGGCGCGA
GOI-R1 CAGCGAGCCGAAGAACACCGGCT
pcs complementation at att sites
pcsR-Fw AGCACCGACAATCCGATAAC
pcsR-Rev TCCTTGCGATGATAGGGCT
doi:10.1371/journal.pone.0030829.t002
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remove planktonic bacteria, and the cells were treated with 0.1%
Triton X-100 for 10 minutes to lyse the epithelial cells. The lysate
was vortexed, serially diluted, and plated on LB and the CFUs/
well were enumerated. To assess biofilm formation, the superna-
tant in the wells was replaced after 1 hour of initial inoculation
with fresh MEM and the plates were incubated at 37uC and 5%
CO2 for 5 hours. After 5 hours the epithelial cells were rinsed with
PBS and treated with 0.1% Triton X-100 to lyse the epithelial
cells. CFUs in the lysates were enumerated as mentioned above.
Each assay was performed at least in triplicate.
P. aeruginosa –Candida albicans co-culture experiments
Co-culture experiments and microscopy were performed as
described by Hogan et al. previously [31]. P. aeruginosa and
constitutively-filamentous Candida albicans nrg1/nrg1 [51] strain
were inoculated into MOPS-glucose medium with or without
choline as described in the text, and co-cultured for 48 hours.
Aliquots from co-culture tubes were observed under a phase
contrast microscope to analyze biofilm formation on the fungal
surface.
T3SS and PlcH assays
While P. aeruginosa PAO1 strains can form biofilms on airway
epithelial cells in a co-culture model, PA14 strains are highly
cytotoxic and lyse the epithelial cells [29,30]. The T3SS-mediated
cytotoxicity of P. aeruginosa PA14 and its Dpcs mutant derivative
towards epithelial cells was examined using a protocol previously
described by Anderson and O’Toole [29]. P. aeruginosa and CFBE
epithelial cells were co-cultured for 5 hours, as described above.
After the incubation period, the culture medium was collected
from each well and centrifuged to sediment the bacteria. Cell
death and cell lysis were quantified, based on the measurement of
lactate dehydrogenase (LDH) activity released from the cytosol of
damaged cells into the supernatant. LDH levels within the cell-free
supernatant were assayed using the Promega CytoTox 96
nonradioactive cytotoxicity assay according to manufacturer’s
instruction (Promega, USA). Percent LDH release (marker of cell
lysis) was calculated relative to that of the uninfected control,
which was set at 0% LDH release, and that of cells lysed with
Triton X-100, which was set at 100% LDH release. Phospholipase
C activity was measured using p-nitrophenyl phosphorylcholine
(NPPC) as described before by Kurioka and Matsuda [40].
Bacteria were grown overnight in 5 ml of MOPS medium with
20 mM Pyruvate with or without 5 mM choline at 37uC. The
reaction buffer was 100 mM Tris-HCl (pH 7.2), 25% glycerol,
and 20 mM NPPC. NPPC hydrolysis was detected by measuring
the absorbance at 410 nm. Assays were performed in triplicate.
Mouse Lung Infection
The P. aeruginosa mouse model of acute pneumonia was
performed as previously described [41]. Briefly, overnight LB
cultures of P. aeruginosa were measured by OD600, pelleted, washed
twice with PBS, and resuspended to give ,3610
7 P. aeruginosa cells
in 40 mL. Actual inoculum was determined by serial dilution of the
input bacterial suspension on Pseudomonas Isolation Agar (PIA,
Difco). Adult male C57Bl/6J mice, 8–12 weeks old (Jackson Labs),
were inoculated with ,3610
7 CFU of P. aeruginosa PAO1 or
isogenic Dpcs via oropharyngeal aspiration following brief
anesthesia with isoflourane. The mice were anesthetized 24 hours
post-infection with intraperitoneal sodium pentobarbital, tracheas
were cannulated and bronchoalveolar lavage fluid (BALF)
collected. Lungs were excised and immediately placed into 1 mL
of cold PBS followed by homogenization. Viable bacterial counts
in lungs were determined by plating serial dilutions of organ
homogenate onto PIA plates followed by incubation at 37uC for
24 hours. WBC counts in the BALF were done using an Advia
automated cell counter (Siemens).
Phenotypic characterization of P. aeruginosa PA14 Dpcs
using Biolog phenotypic microarrays
For global phenotypic characterization of the role of phospha-
tidylcholine in P. aeruginosa, Biolog microarrays were utilized [52].
P. aeruginosa PA14 WT and the isogenic Dpcs mutant were tested
for phenotypic changes using microtiter plates PM9–PM20. Plates
PM9–PM20 measure sensitivities to high osmolality, pH and
different classes of antibiotics, antimetabolites and other inhibitors
(www.biolog.com). The assays were performed with IF-10 medium
(Biolog, Hayward, CA) supplemented with 1 mM choline
chloride. Under these conditions, P. aeruginosa forms PC in its
membranes (analysis of phospholipid profiles by TLC, data not
shown). Growth kinetics of PA14 WT and PA14 Dpcs mutant were
compared by monitoring the cell respiration under individual
conditions of the array, based on reduction of a reporter
tetrazolium dye. Incubation, recording and analysis of the
phenotypic data was performed by Biolog (Hayward, CA) using
the OmnilogH system.
Statistical analyses
One-factor analysis of variance (ANOVA) and t tests were
performed using Prism 5.0 (GraphPad Software).
Supporting Information
Figure S1 Phospholipid profiles of clinical isolates of P.
aeruginosa grown overnight in LB medium. Separation of
phospholipids by 1-D thin layer chromatography and detection by
charring with sulphuric acid solution. The labels NM1, NM2, M1
and M2 represent PL profiles of four independent clinical isolates.
Spots were determined by comparison with migration of
phospholipid standards run in parallel (data not shown). Figure
is a representative image of observations from two independent
experiments.
(DOCX)
Figure S2 Levels of infiltrating white blood cells in
bronchoalveolar lavage fluid (BALF) were similar in
PAO1 WT and PAO1 Dpcs mutant-infected mice. WBC
infiltration into the BALF as measured by automated counter
(Advia). Mean 6 SEM plotted for 6 mice/group and were not
significantly different (P value .0.05).
(DOCX)
Figure S3 Data for Biolog phenotypic microarray PM 9–
20 comparing P. aeruginosa PA14 WT and PA14 Dpcs
mutant. Sensitivity towards osmolytes (PM9), pH (PM10),
antibiotics, antimicrobial peptides and chemical inhibitors
(PM11-20) was tested in this study (1152 conditions were tested,
the description of the plates are available on http://www.biolog.
com/pdf/PM11-PM20.pdf). The growth kinetics of P. aeruginosa
strains grown under different conditions for 24 hours were
analyzed by OmnilogH system which monitored reduction of a
tetrazolium dye due to bacterial respiration. In the figures, growth
advantage of PA14 wild type is indicated as red, while that of the
PA14 Dpcs mutant is shown as green. When the strains grew
equally well, the red and green kinetic curves overlapped which
are displayed as yellow curves. Black boxes around individual wells
indicate instances where differences in growth kinetics were
observed. Two replicate runs were performed. While both runs
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PA14 Dpcs mutant, it is important to note that most of these
differences were not observed in the technical replicates. The
phenotypes detected in the run shown include the wild type having
a growth advantage in (PM10-G11) pH 9.5+TMAO, (PM15-F8)
oleandomycin, (PM18-G2) triclosan, (PM18-H8) 2 phenyl-phenol,
(PM19-G1) laurylsulfobetaine, (PM20-G12) 8-hydroxyquinoline,
and the pcs mutant with an advantage in (PM12-F8) sulphathia-
zole, (PM16-C4) dicholorofuramide, (PM16-C9,10) cetylpyridi-
nium chloride, (PM17-H2) cefsulodin, (PM20-D12) phenylmethyl-
sulfonylfluoride, (PM20-F8) oxytetracycline, (PM20-H12) trole-
andomycin. In the run not shown, the wild type had a slight
growth advantage in (PM9-G2) sodium phosphate pH 7.0
(50 mM), (PM11-C8) colistin, (PM12-E8) sulfadiazine, (PM15-
D5) domiphen bromide, (PM16-E11) rifamycin, (PM16-F6,7)
sodium selenite, (PM16-G3) chromium chloride, (PM19-F4)
phenithicillin, (PM20-E12) hexachlorophene, and the Dpcs mutant
showed growth advantages in (PM12-D9,10) novobiocin, (PM15-
E1,2) alexidine, (PM16-A9,10,11,12) 5-chloro-7-iodo-8-hydroxy-
quinoline, (PM16-F1) potassium tellurite. None of these results
were observed in both of the replicate runs. In the run shown,
PA14 WT had a growth advantage over PA14 Dpcs in the presence
of sodium lactate (PM9-F1,2) and 5-fluoroorotic acid (PM12-
F9,10,11,12), and neither PA14 WT nor PA14 Dpcs grew in the
presence of the compounds in the replicate run. The growth of P.
aeruginosa PA14 WT, Dpcs mutant and Dpcs complemented strain in
media with either 5-fluroorotic acid and sodium lactate was tested.
No differences were observed in the growth rates of PA14 Dpcs
when compared to the wild type strains (data not shown).
(DOCX)
Table S1 Clinical isolates of P. aeruginosa synthesize
PC but only during exogenous availability of choline. The
strains were grown overnight in LB, MOPS medium with 20 mM
glucose and MOPS medium with 20 mM choline media.
Phospholipids were extracted and the profiles were analyzed by
thin-layer chromatography and charring as described. ‘+’ sign
indicates synthesis of PC whereas ‘2’ sign indicates absence of PC
synthesis. PC standards and phospholipids extracted from LB
grown PAO1 and PA14 WT strains served as controls.
(DOCX)
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